Yungjin Pharm Co., Ltd.

Huen Co., Ltd.

Curome Biosciences Co., Ltd.

Whee Seong Lee

Seung Hoon Lee

Mi Jung Lee

Tae Hwan Kwak

You-Hui Lee

Tae Cheul Roh

Kyu Dae Lee

Bo Jung Kim

Eun Ju Lee

In Seok Ko

Disclosed are a compound represented by Formula (1) below, or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein Rto R,and Xto Xare the same as defined in claim

1,2-naphthoquinone based derivative and method of preparing the same

Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same:

Growing community of inventors

Suwon-si, South Korea

Whee Seong Lee